Nico T Mutters
Overview
Explore the profile of Nico T Mutters including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
737
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vaupel F, Kupke K, Mutters N, Scheid P, Weppler R, Dohla M
Disaster Med Public Health Prep
. 2025 Feb;
19:e25.
PMID: 39911070
The reprocessing of personal protective equipment that is only intended for single use has been brought into focus by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, especially regarding...
2.
Righi E, Mutters N, Guirao X, Toro M, Eckmann C, Friedrich A, et al.
Clin Microbiol Infect
. 2024 Aug;
30(12):1537-1550.
PMID: 39154859
Scope: The aim of these guidelines is to provide recommendations for decolonization and perioperative antibiotic prophylaxis (PAP) in multidrug-resistant Gram-positive bacteria (MDR-GPB) adult carriers before inpatient surgery. Methods: These European...
3.
Erler T, Droop F, Lubbert C, Knobloch J, Carlsen L, Papan C, et al.
Sci Total Environ
. 2024 Aug;
950:175344.
PMID: 39117207
The widespread dissemination of carbapenem-resistant bacteria in wastewater systems, particularly from clinical sources, poses a significant public health risk. This study assessed the concentrations and distributions of extracellular DNA (exDNA)...
4.
Kunzler A, Iannizzi C, Burns J, Metzendorf M, Voigt-Radloff S, Piechotta V, et al.
J Clin Epidemiol
. 2024 Jul;
173:111456.
PMID: 39002765
Objectives: We present the 'COVID-19 evidence ecosystem' (CEOsys) as a German network to inform pandemic management and to support clinical and public health decision-making. We discuss challenges faced when organizing...
5.
Vaupel F, Fengler I, Mutters N, Scheid P, Sib E, Weppler R, et al.
Disaster Med Public Health Prep
. 2024 Apr;
18:e91.
PMID: 38682448
The effect of filtering face piece grade 2 (FFP2) masks for infection prevention is essential in health care systems; however, it depends on supply chains. Efficient methods to reprocess FFP2...
6.
Savin M, Sib E, Heinemann C, Eichel V, Nurjadi D, Klose M, et al.
Environ Int
. 2024 Mar;
186:108603.
PMID: 38547543
Acinetobacter baumannii has become a prominent nosocomial pathogen, primarily owing to its remarkable ability to rapidly acquire resistance to a wide range of antimicrobial agents and its ability to persist...
7.
Gebel J, Rausch M, Bienentreu K, Droop F, Eggers M, Gebel L, et al.
GMS Hyg Infect Control
. 2024 Feb;
19:Doc03.
PMID: 38404411
Aims: To evaluate a newly developed microscale quantitative suspension test compared to the existing standard suspension test using determination of the bactericidal and yeasticidal activity of glutaral as one step...
8.
Krefting D, Mutters N, Pryss R, Sedlmayr M, Boeker M, Dieterich C, et al.
Stud Health Technol Inform
. 2024 Jan;
310:1271-1275.
PMID: 38270019
To understand and handle the COVID-19 pandemic, digital tools and infrastructures were built in very short timeframes, resulting in stand-alone and non-interoperable solutions. To shape an interoperable, sustainable, and extensible...
9.
Kociurzynski R, DAmbrosio A, Papathanassopoulos A, Burkin F, Hertweck S, Eichel V, et al.
Sci Rep
. 2023 Dec;
13(1):21321.
PMID: 38044369
Accurate forecasting of hospital bed demand is crucial during infectious disease epidemics to avoid overwhelming healthcare facilities. To address this, we developed an intuitive online tool for individual hospitals to...
10.
Savoldi A, Mutters N, Tacconelli E
Antimicrob Steward Healthc Epidemiol
. 2023 Sep;
3(1):e151.
PMID: 37771739
Personalized medicine has been progressively implemented in several diagnostic and therapeutic patients' algorithms, based on the common assumption that tailoring interventions, practices, and/or therapies to individual patients' clinical, biological, epidemiological,...